By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

CeriBell, Inc. (CBLL)

NASDAQ Currency in USD
$11.56
+$0.12
+1.05%
Last Update: 11 Sept 2025, 20:00
$423.84M
Market Cap
-7.97
P/E Ratio (TTM)
Forward Dividend Yield
$10.01 - $32.75
52 Week Range

CBLL Stock Price Chart

Explore CeriBell, Inc. interactive price chart. Choose custom timeframes to analyze CBLL price movements and trends.

CBLL Company Profile

Discover essential business fundamentals and corporate details for CeriBell, Inc. (CBLL) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Devices

IPO Date

Employees

281.00

CEO

Xingjuan Chao

Description

CeriBell, Inc. develops AI based point-of-care electroencephalography (EEG) technology for the detection and treatment of neurological conditions. The company develops Ceribell System, a novel, point-of-care EEG platform to address the unmet needs of patients in the acute care setting. It also offers EEG disposable headbands; and pocket-sized battery-operated recorders. The company was formerly known as Brain Stethoscope, Inc. and changed its name to CeriBell, Inc. in August 2015. The company was incorporated in 2014 and is based in Sunnyvale, California.

CBLL Financial Timeline

Browse a chronological timeline of CeriBell, Inc. corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 Nov 2025

EPS estimate is -$0.43.

Earnings released on 5 Aug 2025

EPS came in at -$0.38 surpassing the estimated -$0.40 by +5.00%, while revenue for the quarter reached $21.20M , missing expectations by -2.57%.

Earnings released on 8 May 2025

EPS came in at -$0.36 surpassing the estimated -$0.43 by +16.28%, while revenue for the quarter reached $20.49M , missing expectations by -0.25%.

Earnings released on 25 Feb 2025

EPS came in at -$0.40 falling short of the estimated -$0.32 by -25.00%, while revenue for the quarter reached $18.53M , missing expectations by -3.98%.

Earnings released on 12 Nov 2024

EPS came in at -$1.85 falling short of the estimated -$0.82 by -125.61%, while revenue for the quarter reached $17.20M , missing expectations by -2.00%.

Earnings released on 11 Oct 2024

EPS came in at -$1.59 , while revenue for the quarter reached $14.86M .

Earnings released on 31 Mar 2024

EPS came in at -$1.59 , while revenue for the quarter reached $14.86M .

Earnings released on 31 Dec 2023

EPS came in at -$0.35 , while revenue for the quarter reached $13.13M .

Earnings released on 30 Sept 2023

EPS came in at -$0.30 , while revenue for the quarter reached $11.61M .

Earnings released on 30 Jun 2023

EPS came in at -$1.35 , while revenue for the quarter reached $10.24M .

Earnings released on 31 Mar 2023

EPS came in at -$1.35 , while revenue for the quarter reached $10.24M .

CBLL Stock Performance

Access detailed CBLL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run